Alaunos Therapeutics announced an acquisition and a $350 million oversubscribed private placement to support multiple proof-of-concept datasets in pulmonary arterial hypertension.
Observed price moves
- TCRT+14.36%10 min after this headline
MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.